TALKSPACE INC (TALK) Stock Fundamental Analysis

USA Nasdaq NASDAQ:TALK • US87427V1035

3.9 USD
+0.04 (+1.04%)
At close: Feb 10, 2026
3.88 USD
-0.02 (-0.51%)
After Hours: 2/10/2026, 8:00:00 PM
Fundamental Rating

5

TALK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While TALK has a great health rating, there are worries on its profitability. TALK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year TALK was profitable.
  • TALK had a positive operating cash flow in the past year.
  • In the past 5 years TALK reported 4 times negative net income.
  • TALK had negative operating cash flow in 4 of the past 5 years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • TALK has a better Return On Assets (3.29%) than 65.69% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.89%, TALK is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Profit Margin of TALK (1.98%) is better than 60.78% of its industry peers.
  • TALK has a better Gross Margin (43.27%) than 71.57% of its industry peers.
  • In the last couple of years the Gross Margin of TALK has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.98%
GM 43.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

  • TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, TALK has more shares outstanding
  • TALK has more shares outstanding than it did 5 years ago.
  • TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • TALK has an Altman-Z score of 18.88. This indicates that TALK is financially healthy and has little risk of bankruptcy at the moment.
  • TALK has a Altman-Z score of 18.88. This is amongst the best in the industry. TALK outperforms 99.02% of its industry peers.
  • There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.88
ROIC/WACCN/A
WACC8.86%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • TALK has a Current Ratio of 5.91. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.91, TALK belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
  • A Quick Ratio of 5.91 indicates that TALK has no problem at all paying its short term obligations.
  • The Quick ratio of TALK (5.91) is better than 95.10% of its industry peers.
Industry RankSector Rank
Current Ratio 5.91
Quick Ratio 5.91
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 400.00% over the past year.
  • TALK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.37%.
  • Measured over the past years, TALK shows a very strong growth in Revenue. The Revenue has been growing by 37.48% on average per year.
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 172.10% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, TALK will show a very strong growth in Revenue. The Revenue will grow by 21.05% on average per year.
EPS Next Y421.53%
EPS Next 2Y259.39%
EPS Next 3Y172.1%
EPS Next 5YN/A
Revenue Next Year20.73%
Revenue Next 2Y21.48%
Revenue Next 3Y20.36%
Revenue Next 5Y21.05%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 130.00, the valuation of TALK can be described as expensive.
  • TALK's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 28.03. TALK is valued rather expensively when compared to this.
  • TALK is valuated quite expensively with a Price/Forward Earnings ratio of 30.19.
  • TALK's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, TALK is valued at the same level.
Industry RankSector Rank
PE 130
Fwd PE 30.19
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TALK indicates a slightly more expensive valuation: TALK is more expensive than 65.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 230.26
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TALK's earnings are expected to grow with 172.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y259.39%
EPS Next 3Y172.1%

0

5. Dividend

5.1 Amount

  • No dividends for TALK!.
Industry RankSector Rank
Dividend Yield 0%

TALKSPACE INC

NASDAQ:TALK (2/10/2026, 8:00:00 PM)

After market: 3.88 -0.02 (-0.51%)

3.9

+0.04 (+1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners61.55%
Inst Owner Change-0.19%
Ins Owners4.22%
Ins Owner Change2.93%
Market Cap646.07M
Revenue(TTM)214.59M
Net Income(TTM)4.24M
Analysts83.08
Price Target5.1 (30.77%)
Short Float %3.91%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-46.51%
Min EPS beat(2)-100%
Max EPS beat(2)6.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)1.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)7
Avg Revenue beat(12)1.38%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)2.94%
PT rev (3m)4.17%
EPS NQ rev (1m)4.31%
EPS NQ rev (3m)7.29%
EPS NY rev (1m)12.2%
EPS NY rev (3m)22.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE 130
Fwd PE 30.19
P/S 3.01
P/FCF N/A
P/OCF 89.25
P/B 5.92
P/tB 5.92
EV/EBITDA 230.26
EPS(TTM)0.03
EY0.77%
EPS(NY)0.13
Fwd EY3.31%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.04
OCFY1.12%
SpS1.3
BVpS0.66
TBVpS0.66
PEG (NY)0.31
PEG (5Y)N/A
Graham Number0.67
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.98%
GM 43.27%
FCFM N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 395.89%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion 336.23%
Profit Quality N/A
Current Ratio 5.91
Quick Ratio 5.91
Altman-Z 18.88
F-Score7
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y421.53%
EPS Next 2Y259.39%
EPS Next 3Y172.1%
EPS Next 5YN/A
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%
Revenue Next Year20.73%
Revenue Next 2Y21.48%
Revenue Next 3Y20.36%
Revenue Next 5Y21.05%
EBIT growth 1Y98.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year431.24%
EBIT Next 3Y133.53%
EBIT Next 5Y109.41%
FCF growth 1Y94.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.89%
OCF growth 3YN/A
OCF growth 5YN/A

TALKSPACE INC / TALK FAQ

What is the fundamental rating for TALK stock?

ChartMill assigns a fundamental rating of 5 / 10 to TALK.


Can you provide the valuation status for TALKSPACE INC?

ChartMill assigns a valuation rating of 3 / 10 to TALKSPACE INC (TALK). This can be considered as Overvalued.


What is the profitability of TALK stock?

TALKSPACE INC (TALK) has a profitability rating of 2 / 10.


What is the valuation of TALKSPACE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TALKSPACE INC (TALK) is 130 and the Price/Book (PB) ratio is 5.92.